Adults with type 1 diabetes using one of three GLP-1-based medications had significantly greater reductions in body weight ...

Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular events.

Advice on managing severe obesity, including where eligibility criteria or medical history may preclude the use of ...

Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to people with diabetes and those who are classified as morbidly obese.

Weight-loss surgery dramatically outperformed GLP-1 medications in improving longevity and reducing heart, kidney, and eye complications for people with obesity and diabetes. Over 10 years, patients ...

A woman who had to go cold turkey on Mounjaro after it shot up by £211-per-month has revealed the one thing she’s done to keep the weight off. Aimee Young, 38, lost 3st in eight months after taking ...

What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to ...

The drug, called Rybelsus, is the only oral GLP-1 medication available. It was previously approved to treat Type 2 diabetes ...

A PwC analysis shows that GLP-1 medications like Ozempic and Zepbound may be catalyzing a behavioral and economic shift that’s on par with major technological breakthroughs. A transformation that ...

There's growing interest among women to take GLP-1 drugs like semaglutide for weight loss after giving birth and while ...

Novo Nordisk announced its oral GLP-1 has been approved by the FDA to reduce risk for major adverse cardiovascular events in ...